Oragenics Inc. Stock
Your prediction
Pros and Cons of Oragenics Inc. in the next few years
Pros
?
S********** s********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Oragenics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Oragenics Inc. | - | - | - | - | - | - | - |
| Solasia Pharma KK | -4.170% | 7.463% | 24.138% | -28.713% | 8.271% | -45.455% | -86.019% |
| Larimar Therapeutics Inc. | -2.660% | -2.825% | -7.527% | 9.554% | 3.614% | -1.714% | -62.811% |
| Northwest Biotherapeutics Inc. | 0.000% | 36.364% | 12.500% | -7.216% | -12.621% | -59.641% | -83.636% |
Comments
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat